Bio-Techne Corp Price Today
Bio-Techne Corp
TECH
Healthcare
$10.72B
💰
Market Cap
49.1
💸
Price to Earnings
$1.4
🎉
EPS
+45
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
8 |
Hold |
3 |
Sell |
0 |
Strong Sell |
0 |
TECH Price Forecast Target
68.2 👉 95.0 +39%
TECH EPS Forecast
1.4 👉 2.0 +45%
Financials
Profit Margin
20 %
Revenue Growth
0.4 %
Dividend
$ 0.32
Held Percent
1.0% - Insiders
100.5% - Institutions
-1.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $1.2B
-
💰 Blackrock Inc. $1.2B
-
💰 State Street Corporation $431.7M
-
💰 BAMCO Inc. $365.1M
-
💰 Select Equity Group, Inc. $311.0M
Stock Ideas
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…📮FAQ
Some Frequently Asked Questions.
The Bio-Techne Corp industry is Biotechnology
The Bio-Techne Corp sector is Healthcare
The Bio-Techne Corp forecasted predicted Price to Earnings PE ratio is 33.9
The Bio-Techne Corp Price to Earnings PE ratio is 49.1
The Market Capitalization of Bio-Techne Corp is $10.72B
There are total of 155394984 float shares with 100.5% held by Institutions and 1.0% held by insiders
The MBio-Techne Corp forecasted Earnings per Share EPS is $2.0
The Bio-Techne Corp Earnings per Share EPS is 1.4
The Bio-Techne Corp company has $0 gross profits with 20 profit margins
The Bio-Techne Corp Earnings Growth is -0.452% with -0.451% quarterly earnings growth
The Bio-Techne Corp Revenue is $1144999040 with 0.004 revenue growth
The price target for Bio-Techne Corp stock is $95.0 for the high target and $65.0 for the low target
The consensus analyst recommendations for Bio-Techne Corp is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bio-Techne Corp is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 8
- Hold: 3
- Sell: 0
- Strong Sell: 0
The Beta of Bio-Techne Corp is 1.2
The dividend of Bio-Techne Corp is $0.32
The dividend yield of Bio-Techne Corp is 0.0047%
The biggest institutional and mutual fund holders of Bio-Techne Corp stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- BAMCO Inc.
The Bio-Techne Corp ESG Score is 45, with the following breakdown:
- E: 56.89
- S: 56.41
- G: 48.85